Literature DB >> 12101072

Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion.

Marina G Smirnova1, Sergei L Kiselev, Nickolai V Gnuchev, John P Birchall, Jeffrey P Pearson.   

Abstract

Inflammation in the middle ear mucosa, caused usually by bacterial and viral pathogens, is the primary event in the middle ear predisposing the development of otitis media with effusion (OME). Numerous inflammatory mediators have been identified in OME. However, cytokines play a central role as initiators, mediators and regulators of middle ear inflammation and subsequent molecular-pathological processes in middle ear tissues, leading to histopathological changes in the middle ear cavity and the pathogenesis of OME. In this article, we aim to present an overview of current research developments in the pro-inflammatory cytokine involvement in the aetiology of otitis media with effusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101072

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  31 in total

1.  Altered expression of middle and inner ear cytokines in mouse otitis media.

Authors:  Carol J MacArthur; De-Ann M Pillers; Jiaqing Pang; J Beth Kempton; Dennis R Trune
Journal:  Laryngoscope       Date:  2011-01-13       Impact factor: 3.325

2.  Patterns of cytokine profiles differ with pregnancy outcome and ethnicity.

Authors:  Digna R Velez; Stephen J Fortunato; Nicole Morgan; Todd L Edwards; Salvatore J Lombardi; Scott M Williams; Ramkumar Menon
Journal:  Hum Reprod       Date:  2008-05-16       Impact factor: 6.918

3.  Cochlin in normal middle ear and abnormal middle ear deposits in DFNA9 and Coch (G88E/G88E) mice.

Authors:  Nahid G Robertson; Jennifer T O'Malley; Cheng Ai Ong; Anne B S Giersch; Jun Shen; Konstantina M Stankovic; Cynthia C Morton
Journal:  J Assoc Res Otolaryngol       Date:  2014-07-22

4.  Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-16       Impact factor: 2.503

5.  Lipopolysaccharide induces proinflammatory cytokines and chemokines in experimental otitis media through the prostaglandin D2 receptor (DP)-dependent pathway.

Authors:  M Eguchi; S Kariya; M Okano; T Higaki; S Makihara; T Fujiwara; K Nagata; H Hirai; S Narumiya; M Nakamura; K Nishizaki
Journal:  Clin Exp Immunol       Date:  2010-12-16       Impact factor: 4.330

6.  Hypoxia-inducible factor and vascular endothelial growth factor pathway for the study of hypoxia in a new model of otitis media with effusion.

Authors:  Qiuhong Huang; Zhigang Zhang; Yiqing Zheng; Qingyin Zheng; Suijun Chen; Yaodong Xu; Yongkang Ou; Zeheng Qiu
Journal:  Audiol Neurootol       Date:  2012-08-15       Impact factor: 1.854

Review 7.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

8.  Influenza-induced inflammation drives pneumococcal otitis media.

Authors:  Kirsty R Short; Patrick C Reading; Lorena E Brown; John Pedersen; Brad Gilbertson; Emma R Job; Kathryn M Edenborough; Marrit N Habets; Aldert Zomer; Peter W M Hermans; Dimitri A Diavatopoulos; Odilia L Wijburg
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

9.  A novel model of spontaneous otitis media with effusion (OME) in the Oxgr1 knock-out mouse.

Authors:  Joseph E Kerschner; Wenzhou Hong; Steven R Taylor; John A Kerschner; Pawjai Khampang; Kay C Wrege; Paula E North
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2012-11-30       Impact factor: 1.675

Review 10.  Interaction Between Allergy and Middle Ear Infection.

Authors:  Jeong-Hoon Oh; Woo Jin Kim
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.